BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Saleem N, Xu S. Overview of High-Risk Medical Device Innovation in Gastroenterology from 2000 to 2014: Enhancing the Pipeline. Dig Dis Sci 2016;61:2165-74. [DOI: 10.1007/s10620-016-4117-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Walter JR, Ghobadi CW, Hayman E, Xu S. Hysteroscopic Sterilization With Essure: Summary of the U.S. Food and Drug Administration Actions and Policy Implications for Postmarketing Surveillance. Obstetrics & Gynecology 2017;129:10-9. [DOI: 10.1097/aog.0000000000001796] [Cited by in Crossref: 18] [Cited by in F6Publishing: 1] [Article Influence: 3.6] [Reference Citation Analysis]
2 Lohman ME, Ghobadi CW, Xu S. Device Safety Implications of the Clinical Data Leading to US Food and Drug Administration Approval of Soft-Tissue Fillers: A Systematic Review. JAMA Facial Plast Surg 2017;19:421-9. [DOI: 10.1001/jamafacial.2017.0082] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
3 Talati RK, Gupta AS, Xu S, Ghobadi CW. Major FDA medical device recalls in ophthalmology from 2003 to 2015. Can J Ophthalmol 2018;53:98-103. [PMID: 29631834 DOI: 10.1016/j.jcjo.2017.08.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
4 Janetos TM, Ghobadi CW, Xu S, Walter JR. Overview of high-risk medical device recalls in obstetrics and gynecology from 2002 through 2016: implications for device safety. Am J Obstet Gynecol 2017;217:42-46.e1. [PMID: 28500861 DOI: 10.1016/j.ajog.2017.03.021] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]